Stock Chart IconStock chart icon

Oracle’s year-to-date stock performance.

Oracle: “…I like the prospects. But you’re in it for the data center, and the data center business is excellent.”

Stock Chart IconStock chart icon

AbbVie’s year-to-date stock performance.

AbbVie: “AbbVie is doing very, very well…My favorite in this group right now, though, remains Abbott Labs.”

Stock Chart IconStock chart icon

Core Scientific’s year-to-date stock performance.

Core Scientific: “…It’s a mini-Palantir. So I think you should just go buy Palantir.”

Stock Chart IconStock chart icon

Clover Health’s year-to-date stock performance.

Clover Health: “I just don’t want to go there. I know that it’s a good company, but I just don’t want to hurt anybody.”

Stock Chart IconStock chart icon

GXO Logistics’ year-to-date stock performance.

GXO Logistics: “Just hold on…This is a very valuable company.”

Stock Chart IconStock chart icon

Sweetgreen’s year-to-date stock performance.

Sweetgreen: “Sweetgreen is terrific, I really like it.”

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer The CNBC Investing Club Charitable Trust holds shares of Abbott Laboratories.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts


This will close in 0 seconds